Recently Featured

GLP-1s Support Heart Attack Recovery in Rodents by Relaxing Tight Blood Vessels

March 8, 2026
Recent research has revealed that GLP-1 receptor agonists, specifically semaglutide and tirzepatide, may play a significant role in aiding heart attack recovery in rodent models. These findings add to the growing body of evidence supporting the cardiovascular benefits of GLP-1s, which have already gained prominence for their efficacy in treating diabetes and promoting weight loss.…

A swine flu case to keep tabs on

March 8, 2026
A recent case of swine flu reported in Spain has raised concerns among public health officials and pharmaceutical professionals alike. The case, which involves a patient exhibiting symptoms consistent with the H1N1 virus, highlights the ongoing risk of influenza outbreaks and the necessity for vigilant monitoring and rapid response strategies within the healthcare system. This…

Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M

March 8, 2026
Bioxytran has announced promising results from its phase 1b/2a clinical trial of ProLectin-M, an antiviral candidate aimed at treating mild to moderate COVID-19. The early data indicate that patients receiving ProLectin-M experienced faster viral clearance compared to those on placebo, alongside a favorable safety profile. This development is significant as it highlights the potential for…

Pharma Giants Prioritize Employee Safety and Supply Chain Stability Amid Middle East Conflict

March 8, 2026
As the United States and Israel’s recent military actions against Iran create significant geopolitical tensions, major pharmaceutical companies are closely monitoring the safety of their employees in the region. These companies are not only assessing the immediate risks to their workforce but are also taking proactive steps to ensure continued access to medicines in neighboring…

Ongoing Cases